Kingstone Insurance (KINS) Finishes First Again in PIA Company Performance Survey

Kingstone Companies, Inc. (“KINS”) (NASDAQ: KINS) announced today that its wholly-owned subsidiary, Kingstone Insurance Company (“KICO”), finished first in the 2012 PIA Company Performance Survey. This marks the second consecutive first place finish for KICO, which took the top spot in the previous survey done in 2010. The Professional Insurance Agents Assn. (the “PIA”) has stated that the PIA Company Performance Survey, which began in 2002, is the largest and most consistently conducted survey of agent-company relations in the industry.

Barry Goldstein, CEO of both KICO and KINS, explained that “Periodically, the PIA surveys its membership, asking them to rate the carriers they do business with. The survey covers 20 different performance categories such as claims, underwriting, agent support, and technology. In 2012, a total of 103 companies were rated along with KICO. These included well known insurance giants such as Travelers, Chubb, Progressive and Allstate. KICO received the highest rating of all carriers surveyed.” Mr. Goldstein continued, “We take great pride in the results. This reflects KICO’s commitment to providing the highest quality of service to our customers.”

Mr. Goldstein continued, “KICO, about to enter its 127^th year, takes great pride in stressing its partnership with its Selected Producers. We sell only through the independent agent system. We are consistent and fair and always keep the welfare of our producer partners in mind. We treat them, along with our insureds, employees, reinsurers and vendors, with the same respect we expect to receive. None of our policies have ever been sold directly to consumers. We do not appoint an “agency” that is owned by a direct to consumer carrier. We are 100% committed to our producers.”

Forward Looking Statements

Statements in this press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, may be forward-looking statements. These statements are based on management’s current expectations and are subject to uncertainty and changes in circumstances. These statements involve risks and uncertainties that could cause actual results to differ materially from those included in forward-looking statements due to a variety of factors. More information about these factors can be found in Kingstone’s filings with the Securities and Exchange Commission, including its latest Annual Report filed with the Securities and Exchange Commission on Form 10-K. Kingstone undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

UQM Technologies (UQM) Announces Strategic Alliance in China

UQM Technologies, Inc. (NYSE MKT: UQM), has signed a memorandum of understanding with a major Chinese company for the development and marketing of UQM electric propulsion systems for New Energy Vehicles (NEV) in China. This agreement expands the global reach of UQM to four continents, and represents the initial step in our strategy to penetrate the Chinese market with our leading electric propulsion products. With a global reputation for performance and quality, UQM provides its customers with both custom electric propulsion solutions and automotive-qualified volume production capabilities.

Under the agreement, UQM and its China-based partner will work collaboratively to introduce UQM products into the Chinese market for use in New Energy Vehicles. The China State Council published its New Energy Vehicles plan in July, 2012, setting a goal of 500,000 energy-efficient and clean vehicles on the road in China by 2015, and five million vehicles by 2020.

“This agreement is an important step in our strategic plan to enter the Chinese market with our highly efficient electric propulsion systems and related products for New Energy Vehicles,” said Eric R. Ridenour, President and Chief Executive Officer of UQM Technologies, Inc. “With annual revenue of over $5 billion, our Chinese partner has a substantial footprint throughout China and is well-positioned to introduce our products to the country’s developing New Energy Vehicle market.”

UQM powers test-fleet vehicles by Audi in Germany, Rolls-Royce and the London Taxi Company in the U.K., and previously, Saab vehicles in Sweden. UQM is also powering Hino electric city buses in Japan and demonstration vehicles for EV Engineering in Australia. In the U.S., UQM can be found in the CODA all-electric passenger sedan, now available in California, Proterra all-electric composite transit buses, Boulder EV all-electric delivery vans, and Electric Vehicles International all-electric medium-duty trucks and delivery vans.

About UQM

UQM Technologies is a developer and manufacturer of power-dense, high-efficiency electric motors, generators and power electronic controllers for the automotive, commercial truck, bus and military markets. A major emphasis for UQM is developing propulsion systems for electric, hybrid electric, plug-in hybrid electric and fuel cell electric vehicles. UQM is located in Longmont, Colorado. Please visit www.uqm.com for more information.

This Release contains statements that constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. These statements appear in a number of places in this Release and include statements regarding our plans, beliefs or current expectations, including those plans, beliefs and expectations of our officers and directors with respect to, among other things, future orders to be received, future financial results and the continued growth of the electric-powered vehicle industry. Important Risk Factors that could cause actual results to differ from those contained in the forward-looking statements are contained in our Form 10-Q filed July 31, 2012, which is available through our website at www.uqm.com or at www.sec.gov.

GreeneStone (GRST) Supports the Cause of Mental Health with Charitable Foundation

GreeneStone Healthcare Corporation (OTCBB/QB: GRST) (“GreeneStone” or “the Company”) is joining a growing chorus of companies that have taken up the cause of mental with the announcement that it will establish a charitable foundation for the support of those with mental health issues and more particularly with substance abuse problems. Often invisible, mental illness is one of the most pervasive health issues in the country with far-reaching consequences for every person. One in five people will experience a form of mental illness at some point and most will be reluctant to talk to a co-worker, friend or family member about their struggle, let alone seek treatment. The list of companies that are building awareness and raising funds to support mental health continues to grow and includes major corporations, such as Bell Canada.

“Since 2006, we have seen a major drive in Canada to raise awareness of mental health concerns. Mental issues have been stigmatized for too long, and the kinds of campaigns that are being created, such as Bell’s “Let’s Talk” campaign, are bringing this issue into the light of day. We want our foundation to move beyond education and provide practical support for those that suffer,” commented Shawn Leon, CEO of GreeneStone Healthcare Corp.

GreeneStone is a new company in the behavioral treatment sector in Canada, an industry that has been well developed in the US but remains in its early evolutionary stages in Canada. With increased interest from private equity acquirers in recent history, the behavioral treatment sector has moved away from the periphery. Acquirers like Bain Capital and Elements Behavioral have clearly demonstrated the attractiveness of companies that can execute on the operational side in this underserviced market.

In 2010, Bell announced the launch of an unprecedented multi-year charitable program dedicated to the promotion and support of mental health. Over the next several years, this multi-million dollar initiative will support a wide range of programs that will enhance awareness, understanding and treatment of mental illness and promote access to care and research across the country.

Other companies with prominent contributions to the mental health cause include the following:

Intervention Canada (Shaw Media – Slice Network) – Intervention Canada profiles individuals who suffer from drug dependencies or other compulsive behaviours and the resulting personal crisis that has arisen from it. The Canadian series comes after the multiple Emmy-nominated U.S. series broke ground with its shocking look at the problem of addiction. The show brings to light many mental health issues that have for too long gone unnoticed by the public eye.

“Transforming Lives” (Center for Addiction and Mental Health) – “Transforming Lives” is an awareness campaign that focuses on personal stories of Ontarians’ experiences with addiction and mental illness. Both celebrities and non-celebrities have profiled their struggles overcoming addictions and mental illness. Every two years, the Centre for Addiction and Mental Health (CAMH) Foundation honours extraordinary people who have overcome or are overcoming the challenges of living with mental illness and/or addiction and now serve as models of hope and inspiration to others.

The Canada Post Foundation for Mental Health (Canada Post): The Canada Post Foundation for Mental Health raises awareness about mental illness and helps front-line, grassroots organizations. Since its formation in October 2007, the foundation has delivered more than $4.6 million in grants to almost 100 organizations in Canada.

Follow GreeneStone Healthcare Corp. and the company’s activities at the following Facebook sites:

GreeneStone Muskoka: https://www.facebook.com/pages/GreeneStone-Muskoka/510641255628356

GreeneStone Yorkville: https://www.facebook.com/pages/GreeneStone-Yorkville/452197614820117

About GreeneStone Healthcare Corporation

GreeneStone Healthcare Corp. (OTCBB: GRST) is a provider of mental health services, specializing in the areas of addiction treatment, eating disorders, nutrition and weight loss, and executive healthcare. GreeneStone is among the many nascent healthcare companies re-defining the healthcare space for the modern economy, which include Roche Holding Ltd. (OTCQB: RHHBY), Sarepta Therapeutics Inc. (NASDAQ: SRPT), Nektar Therapeutics (NASDAQ: NKTR), Celldex Therapeutics, Inc. (NASDAQ: CLDX), Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN), Zogenix, Inc. (NASDAQ: ZGNX). The company operates medical and healthcare clinics in Ontario, Canada, serving a North American and international clientele. GreeneStone’s clinics meet several ends: (1) GreeneStone adds overflow capacity to an increasingly stretched public healthcare system in Canada, (2) GreeneStone mental health clinics provide private alternatives to publicly available but highly underserviced healthcare subsectors, and (3) GreeneStone meets newly developing healthcare needs undisturbed by the public/private market, such as eating disorders. The company is headquartered in Toronto, Canada.

Notice Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). To the extent that any statements made in this press release contain information that is not historical, these statements are essentially forward-looking. Forward-looking statements can be identified by the use of words such as “expect,” “plan,” “will,” “may,” “anticipate,” “believe,” “should,” “intend,” “estimate,” and variations of such words. Forward-looking statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, those risks and uncertainties contained in this press release and those identified in the periodic reports that the company files with the Securities and Exchange Commission (the “SEC”) pursuant to the Exchange Act.

Investor information and email sign-up:

http://www.greenestoneinvestor.com

Identive (INVE) Announces Increase in Transponder, NFC Orders

SANTA ANA, Calif. and ISMANING, Germany, Oct. 1, 2012 (GLOBE NEWSWIRE) — Identive Group, Inc. (Nasdaq:INVE) (Frankfurt:INV), a provider of products and services for the identification, security and RFID industries, today announced that it has received new customer orders for more than 20 million radio frequency identification (RFID) transponder products, including over 15 million near field communication (NFC) transponders. The orders represent large contracts with customers in the US, Europe and Asia and are due for delivery over the next six months.

“We are very pleased with the uptick in volume of our transponder orders, which represents a 33% increase over our average quarterly production for 2012 to date. Having these orders already in place for Q4 and Q1 points to a recovery in demand for our transponder products in general and a strong increase in demand for innovative NFC applications,” said Dr. Manfred Mueller, executive vice president and COO Identification Products for Identive. Mueller continued, “As previously announced, we are bringing additional production capacity on line in our Singapore plant during Q4, which we expect will accommodate this growing demand.”

Identive offers the world’s broadest range of NFC transponders, readers and reader modules including full tagging solutions and web-based personalization capabilities to address applications for payment, mobility, ticketing, retail and more. For more information visit www.identivenfc.com.

About Identive

Identive Group, Inc. (Nasdaq:INVE) (Frankfurt:INV) is focused on building the world’s signature company in Secure ID. The company’s products, software, systems and services address the markets for identity management, physical and logical access control, cashless payment, NFC solutions and a host of RFID-enabled applications for customers in the government, enterprise, consumer, education and healthcare sectors. Identive’s mission is to build a lasting business of scale and technology based on a combination of strong technology-driven organic growth and disciplined acquisitive expansion. The company delivers up-to-date information on its activity as well as industry trends through its industry-leading social media initiatives and educational resource, AskIdentive.com. For additional information, please visit www.identive-group.com or follow on Twitter at @IdentiveGroup.

The Identive Group, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8072

CONTACT: Darby Dye,
         +1 949 553-4251,
         ddye@identive-group.com

         Lennart Streibel,
         +49 89 9595-5195,
         lstreibel@identive-group.com

SPAR Group (SGRP) to Present at the LD MICRO SUMMIT on Oct 4

TARRYTOWN, NY — (Marketwire) — 10/01/12 — SPAR Group, Inc. (NASDAQ: SGRP) (the “Company” or “SPAR Group”), a leading supplier of retail merchandising and other marketing services throughout the United States and internationally, today announced Mr. Gary Raymond, Chief Executive Officer has been invited to present at the 5th Annual LD Micro Conference in Los Angeles, California on Thursday, October 4th at 4:30 PM EDT. Mr. Raymond will provide an update on the company’s recent acquisitions and participate in a question and answer segment with interested parties.

Conference Details:

• Luxe Sunset Bel Air Hotel, 11461 Sunset Boulevard, Los Angeles, California 90049
• October 4th, 2012
• Further details about the conference can be found at http://www.ldmicro.com/

About SPAR Group
SPAR Group, Inc. is a diversified international merchandising and marketing services Company and provides a broad array of services worldwide to help companies improve their sales, operating efficiency and profits at retail locations. The Company provides merchandising and other marketing services to manufacturers, distributors and retailers worldwide, primarily in mass merchandiser, office supply, grocery, drug, independent, convenience, electronics, toy and specialty stores, as well as providing furniture and other product assembly services, in-store events, radio frequency identification (“RFID”) services, technology services and marketing research. The Company has supplied these project and product services in the United States since certain of its predecessors were formed in 1979 and internationally since the Company acquired its first international subsidiary in Japan in May of 2001. Product services include restocking and adding new products, removing spoiled or outdated products, resetting categories “on the shelf” in accordance with client or store schematics, confirming and replacing shelf tags, setting new sale or promotional product displays and advertising, replenishing kiosks, providing in-store event staffing and providing assembly services in stores, homes and offices. Other merchandising services include whole store or departmental product sets or resets (including new store openings), new product launches, in-store demonstrations, special seasonal or promotional merchandising, focused product support and product recalls. The Company operates throughout the United States and internationally in 10 of the most populated countries, including China and India. For more information, visit the SPAR Group’s website at http://www.sparinc.com/.

Forward Looking Statements
Certain statements in this news release are forward-looking, including (without limitation) expectations or guidance respecting customer contract expansion, growing revenues and profits through organic growth and acquisitions, attracting new business that will increase SPAR Group’s revenues, continuing to maintain costs and consummating any transactions. Undue reliance should not be placed on such forward-looking statements because the matters they describe are subject to known and unknown risks, uncertainties and other unpredictable factors, many of which are beyond the Company’s control. The Company’s actual results, performance and trends could differ materially from those indicated or implied by such statements as a result of various factors, including (without limitation) the continued strengthening of SPAR Group’s selling and marketing functions, continued customer satisfaction and contract renewal, new product development, continued availability of capable dedicated personnel, continued cost management, the success of its international efforts, success and availability of acquisitions, availability of financing and other factors, as well as by factors applicable to most companies such as general economic, competitive and other business and civil conditions. Information regarding certain of those and other risk factors and cautionary statements that could affect future results, performance or trends are discussed in SPAR Group’s most recent annual report on Form 10-K, quarterly reports on Form 10-Q, and other filings made with the Securities and Exchange Commission from time to time. All of the Company’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.

Contact:
James R. Segreto
Chief Financial Officer
SPAR Group, Inc.
(914) 332-4100

Investors:
Alan Sheinwald
Alliance Advisors, LLC
(212) 398-3486
Email Contact

Chris Camarra
Alliance Advisors, LLC
(212) 398-3487

FONAR (FONR) Reports Record Profits From Operations for Fiscal 2012

FONAR Reports Record Profits From Operations for Fiscal 2012; Net Income Doubles From Fiscal 2011; Revenues Increase 19% to $39.4 Million

MELVILLE, NY — (Marketwire) — 10/01/12 — FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, reported today its year-end financial results for the year-ended June 30, 2012. The Company has now had nine straight quarters of profitability. For the 2012 fiscal year as compared to the 2011 fiscal year, the Company made improvements in revenues and profit across both of its operating segments, those being the UPRIGHT® MRI segment that includes product sales, service and repair fees, and HMCA, its STAND-UP® MRI center management subsidiary. All of these utilize the FONAR UPRIGHT® Multi-Position™ MRI which is also known as the STAND-UP® MRI.

Statement of Income Items

Total net income for the year ended June 30, 2012, more than doubled, an increase of 108% to $6.9 million, from $3.3 million for the year ended June 30, 2011.

Income from operations increased 90% from $3.8 million, for the year ended June 30, 2011, to $7.2 million for the year ended June 30, 2012.

Basic net income per common share available to common stockholders for the year ended June 30, 2012, was $0.93, an increase of 66% over the previous year ended June 30, 2011 of $0.56.

Diluted net income per common share available to common stockholders for the year ended June 30, 2012, was $0.91, an increase of 65% over the previous year ended June 30, 2011, of $0.55.

Total revenues for the UPRIGHT® MRI segment increased 5% to $18.7 million for the year ended June 30, 2012 as compared to $17.8 million for the year ended June 30, 2011. Total costs related to revenues for the UPRIGHT® MRI segment increased just 1% to $8.9 million for the year ended June 30, 2012 as compared to $8.8 million for the year ended June 30, 2011

Total revenues for the HMCA subsidiary, the STAND-UP® MRI center management segment increased 35% to $20.7 million for the year ended June 30, 2012 as compared to $15.3 million for the year ended June 30, 2011. Total costs related to revenues for HMCA increased just 27% to $12.3 million for the year ended June 30, 2012 as compared to $9.7 million for the year ended June 30, 2011.

Collectively, total revenues increased 19% to $39.4 million for the year ended June 30, 2012, as compared to $33.1 million, for the year ended June 30, 2011. Total costs related to total revenues increased 15% to $21.2 million for the year ended June 30, 2012, as compared to the prior year ended June 30, 2011, at $18.5 million.

Overhead consisting of research & development (R&D) and selling, general & administrative costs (S,G&A) rose only 1% to $10.0 million for the year ended June 30, 2012 from $9.9 million for the year ended June 30, 2011.

Balance Sheet Items

Total assets increased 6% to $33.6 million for the year ended June 30, 2012 as compared to the previous fiscal year when total assets were $31.6 million.

At June 30, 2012, total cash and cash equivalents were $12.0 million, total current assets were $25.9 million, total current liabilities were $21.1 million, and total long-term liabilities were $1.5 million. Also, total stockholders’ equity was $11.1 million, as of June 30, 2012.

See the accompanying tables for more details.

Significant Highlights in Fiscal 2012

HMCA, FONAR’s STAND-UP® MRI center management subsidiary, added a center in Yonkers, NY, in January 2012. This brings the total number of managed MRI scanning centers to eleven. HMCA managed centers have added patient volume significantly for the past two years. During the years ended June 30 for 2010, 2011 and 2012, approximately 33,100, 38,600 and 43,700 MRI scans were performed, respectively, at the HMCA centers. HMCA is actively pursuing additional management contracts, primarily in New York and Florida.

While the STAND-UP® MRI center management segment is the fastest growing segment of FONAR’s business, manufacturing and selling the FONAR UPRIGHT® Multi-Position™ MRI is a principal part of this business. Among the recent sales and installations was Oklahoma UPRIGHT MRI in Oklahoma City (www.okuprightmri.com). That sale, announced on November 30, 2011, was notable that it had become the 29th state that had purchased a FONAR UPRIGHT® Multi-Position™ MRI for its citizens.

Within the year, the company sold and installed an UPRIGHT® Multi-Position™ MRI scanner to Parkway Radiology, LLC, Hagerstown, MD. The group who purchased the FONAR UPRIGHT® Multi-Position™ MRI said they wanted the best diagnostic device available to allow them to be a “Center of Excellence for the Spine.” Accordingly, they considered other state-of-the-art MRI scanners, including those with field strengths at 3.0 and 1.5 Tesla, but those systems are single-position only and non weight-bearing. They therefore concluded that to be a “Center of Excellence for the Spine,” it was crucial to have an MRI that could evaluate the spine in its full range of dynamic weight-bearing positions.

In addition, another recent sale is being installed in central California and expects to be operating in October.

Breakthrough in the detection of MS

On October 5, 2011, the Company reported a diagnostic breakthrough in the understanding of the genesis of multiple sclerosis (MS) based on observations made possible by the company’s unique FONAR UPRIGHT® Multi-Position™ MRI. The press release indicated that the cause of multiple sclerosis may be biomechanical and related to earlier trauma to the neck, which can result in the obstruction of the flow of cerebrospinal fluid (CSF), which is produced and stored in the central anatomic structures of the brain known as the ventricles. Since the ventricles produce a large volume of CSF each day (500 cc), an obstruction can result in a build-up of pressure within the ventricles, resulting in leakage of the CSF into the surrounding brain tissue. This leakage could be responsible for generating the brain lesions of multiple sclerosis.

The research was published in the journal Physiological Chemistry and Physics and Medical NMR (Sept. 20, 2011, 41: 1-17), titled “The Possible Role of Cranio-Cervical Trauma and Abnormal CSF Hydrodynamics in the Genesis of Multiple Sclerosis.” It was co-authored by FONAR MRI researchers Raymond V. Damadian, M.D., president and chairman of FONAR, and FONAR scientist David Chu, PhD. The complete study can be viewed at www.fonar.com/pdf/PCP41_damadian.pdf.

Dr. Damadian said, “We used the UPRIGHT® Multi-Position™ MRI to view the flow of cerebrospinal fluid in and out of the brain with the patients scanned UPRIGHT® and scanned lying down. The UPRIGHT® MRI also revealed that these obstructions were the result of structural deformities of the cervical spine, induced by trauma earlier in life. The findings are based on viewing the real-time flow of cerebrospinal fluid in a series of eight randomly chosen patients with multiple sclerosis. These invaluable dual observations have only been possible since the invention by FONAR of an MRI capable of imaging the patient UPRIGHT®.” For more information visit: www.fonar.com.

On October 4, 2011, Dr. Damadian announced the study at a Radiology Department Grand Rounds at the University of California, San Diego Medical Center. William G. Bradley, Jr., M.D., Ph.D., F.A.C.R., Chairman of the Department of Radiology, and a Professor of Radiology at UCSD School of Medicine introduced Dr. Damadian to his colleagues at grand rounds. Dr. Bradley said, “Dr. Damadian has shown that 8 patients with MS had degenerative changes in their cervical spines which impinged on the spinal canal and limited the pulsatile, to-and-fro flow of cervical CSF over the cardiac cycle, as demonstrated on UPRIGHT® MRI. His hypothesis that increased resistance to outflow of CSF is linked to the etiology of MS has some similarities to Dr. P. Zamboni’s hypothesis that MS is due to the impeded outflow of venous blood from the brain due to dural sinus stenoses. In both theories, increased resistance to outflow of either CSF or venous blood would be expected to modify the intracranial pressure wave over the cardiac cycle. While both theories need to be further tested with larger controlled studies, it is intriguing that they seem to invoke similar pathologic changes. Whether these changes are etiologic in all cases of MS remains to be tested.”

On November 2, 2011, FONAR reported on a 41-year-old female patient with MS that had been one of the eight patients in the original study. The FONAR UPRIGHT® MRI had found cervical malrotations at the cranio-cervical junction and alterations of CSF flow dynamics which gave rise to CSF fluid leakages into surrounding brain tissue. The CSF leakages visualized were directly connected to the MS lesions visualized on the UPRIGHT® MRI. Dr. Damadian stated, “These new observations have uncovered biomechanical barriers that appear to lead to multiple sclerosis. It is significant that these barriers may be therapeutically addressable.”

The MS patient was treated by Dr. Scott Rosa, with a proprietary protocol using an Atlas Orthogonal (AO) instrument and the FONAR UPRIGHT® Multi-Position™ MRI. The patient has experienced a significant reduction in symptoms which correlate directly to 28.6% reduction of her CSF pressure on post MRI evaluation. At this time the patient continues to be free of MS symptoms as well as vertigo and vomiting on recumbency. The patient continues being administered by Dr. Rosa.

Management Discussion

Dr. Damadian said, “FONAR has performed an impressive comeback since faltering in 2008 during the banking crisis. We have stabilized and increased our revenues through the successes of our STAND-UP® MRI center management subsidiary. We have cut and stabilized costs. We have even reduced our long term liabilities from June 30, 2011 to June 30, 2012 by 44% to approximately $1.5 million.”

Dr. Damadian continued, “All of this successful activity places FONAR on a course of continued growth and prosperity. How gratifying it is to be able to report to our shareholders record profits from operations for this fiscal year (fiscal 2012). This includes the 4th fiscal quarter of 2012 which had record profits from operations for any quarter ($1.9 million).”

“Leading the way is the FONAR UPRIGHT® Multi-Position™ MRI, which is opening doors in diagnostics that had previously been unavailable,” said Dr. Damadian. “For instance, the observations at the craniocervical junction (CCJ) utilizing our UPRIGHT® MRI are simply amazing. It reminds me of the early days of MRI during the 1970’s and 1980’s when FONAR developed the first MRIs (recumbent) and the diagnostic doors that opened then. Now with the advent of CSF flow imaging and enhanced signal-to-noise RF surface coils specific for the CCJ, we are learning much about a variety of brain and spine diseases.”

About FONAR

FONAR (NASDAQ: FONR), Melville, NY, The Inventor of MR Scanning™, is an American Company that was incorporated in 1978, and is the first, oldest and most experienced MRI company in the industry. FONAR introduced the world’s first commercial MRI in 1980, and went public in 1981. Since its inception, nearly 300 recumbent-OPEN MRIs and over 150 UPRIGHT® Multi-Position™ MRI scanners have been installed worldwide. FONAR’s stellar product is the UPRIGHT® MRI (also known as the STAND-UP® MRI), the only whole-body MRI that performs Position™ imaging (pMRI™) and scans patients in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as the conventional lie-down position. The FONAR UPRIGHT® MRI often sees the patient’s problem that other scanners cannot because they are lie-down only. The patient-friendly UPRIGHT® MRI has a near-zero claustrophobic rejection rate by patients. As a FONAR customer states, “If the patient is claustrophobic in this scanner, they’ll be claustrophobic in my parking lot.” Approximately 85% of patients are scanned sitting while they watch a 42″ flat screen TV. FONAR is headquartered on Long Island, New York.

UPRIGHT® and STAND-UP® are registered trademarks and The Inventor of MR Scanning™, Full Range of Motion™, Multi-Position™, Upright Radiology™, The Proof is in the Picture™, True Flow™, pMRI™, Spondylography™, Dynamic™, Spondylometry™, CSP™, and Landscape™, are trademarks of FONAR Corporation.

This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company’s financial results may be found in the company’s filings with the Securities and Exchange Commission.

                     FONAR CORPORATION AND SUBSIDIARIES
                         CONSOLIDATED BALANCE SHEETS

                      ASSETS
                                                           June 30,
                                                 ---------------------------
                                                      2012          2011
                                                 ------------- -------------
Current Assets:
  Cash and cash equivalents                      $  12,032,015 $   9,251,244
  Accounts receivable - net of allowances for
   doubtful accounts of $1,852,987 and
   $1,777,794 at June 30, 2012 and 2011,
   respectively                                      5,094,687     5,263,903
  Management and other fees receivable - net of
   allowances for doubtful accounts of
   $7,458,345 and $6,508,345 at June 30, 2012
   and 2011, respectively                            3,781,635     3,308,456
  Management and other fees receivable - related
   medical practices - net of allowances for
   doubtful accounts of $403,047 at June 30,
   2012 and at June 30, 2011                         1,311,195     1,668,880
  Costs and estimated earnings in excess of
   billings on uncompleted contracts                 1,128,596       169,443
  Inventories                                        2,194,949     2,400,240
  Current portion of note receivable - net of
   allowances for doubtful accounts of $65,000
   at June 30, 2012 and at June 30, 2011               116,016       114,058
  Prepaid expenses and other current assets            206,328       384,437
                                                 ------------- -------------

  Total Current Assets                              25,865,421    22,560,661

Property and Equipment - Net                         3,173,447     3,769,424

Notes Receivable                                       275,966       358,769

Other Intangible Assets - Net                        3,835,179     4,318,311

Other Assets                                           465,455       573,509
                                                 ------------- -------------

    Total Assets                                 $  33,615,468 $  31,580,674
                                                 ============= =============
                   LIABILITIES
                                                 ------------- -------------
Current Liabilities:
  Current portion of long-term debt and capital
   leases                                        $   1,853,623 $   2,025,836
  Accounts payable                                   2,076,846     2,187,115
  Other current liabilities                          7,693,241     8,236,105
  Unearned revenue on service contracts              5,474,614     5,762,394
  Customer advances                                  3,881,284     4,845,794
  Billings in excess of costs and estimated
   earnings on uncompleted contracts                         -         4,045
  Income tax payable                                   100,000        75,000
                                                 ------------- -------------
    Total Current Liabilities                       21,079,608    23,136,289
                                                 ------------- -------------
Long-Term Liabilities:
  Accounts payable                                      47,600       102,000
  Due to related medical practices                     228,741       228,267
  Long-term debt and capital leases, less
   current portion                                     777,274     1,746,286
  Other liabilities                                    400,714       502,018
                                                 ------------- -------------
  Total Long-Term Liabilities                        1,454,329     2,578,571
                                                 ------------- -------------
Total Liabilities                                   22,533,937    25,714,860
                                                 ------------- -------------

                     FONAR CORPORATION AND SUBSIDIARIES
                        CONSOLIDATED BALANCE SHEETS

                            STOCKHOLDERS' EQUITY
                                                         June 30,
                                               ----------------------------
                                                    2012           2011
                                               -------------  -------------
Stockholders' Equity:

  Class A non-voting preferred stock $.0001
   par value; 453,000 shares authorized at
   June 30, 2012 and June 30, 2011, 313,438
   issued and outstanding at June 30, 2012 and
   2011                                        $          31  $          31

  Preferred stock $.001 par value; 567,000
   shares authorized at June 30, 2012 and June
   30, 2011, issued and outstanding - none                 -              -

  Common stock $.0001 par value; 8,500,000
   shares authorized at June 30, 2012 and June
   30, 2011, 5,912,905 and 5,636,571 issued at
   June 30, 2012 and 2011, respectively;
   5,901,262 and 5,624,928 outstanding at June
   30, 2012 and 2011, respectively                       590            562

  Class B common stock (10 votes per share)
   $.0001 par value; 227,000 shares authorized
   at June 30, 2012 and June 30, 2011, 158
   issued and outstanding at June 30, 2012 and
   2011                                                    -              -

  Class C common stock (25 votes per share)
   $.0001 par value; 567,000 shares authorized
   at June 30, 2012 and June 30, 2011, 382,513
   issued and outstanding at June 30, 2012 and
   2011                                                   38             38

  Paid-in capital in excess of par value         174,084,007    173,476,059

  Accumulated other comprehensive loss               (19,534)       (16,179)

  Accumulated deficit                           (168,333,958)  (174,110,439)

  Notes receivable from employee stockholders        (70,813)      (115,305)

  Treasury stock, at cost - 11,643 shares of
   common stock at June 30, 2012 and 2011           (675,390)      (675,390)

  Non controlling interests                        6,096,560      7,306,437
                                               -------------  -------------

  Total Stockholders' Equity                      11,081,531      5,865,814
                                               -------------  -------------

  Total Liabilities and Stockholders' Equity   $  33,615,468  $  31,580,674
                                               -------------  -------------

                     FONAR CORPORATION AND SUBSIDIARIES
                     CONSOLIDATED STATEMENTS OF INCOME

                                               For the Years Ended June 30,
                                               ----------------------------
                                                    2012           2011
                                               -------------  -------------
Revenues
  Product sales - net                          $   6,922,465  $   6,682,297
  Service and repair fees - net                   11,674,541     10,936,839
    Service and repair fees - related parties
     - net                                           110,000        192,500
  Management and other fees - net                 14,060,275     10,170,086
    Management and other fees - related
     medical practices - net                       6,677,138      5,154,673
                                               -------------  -------------
  Total Revenues - Net                            39,444,419     33,136,395
                                               -------------  -------------
Costs and Expenses
  Costs related to product sales                   5,387,923      5,768,601
  Costs related to service and repair fees         3,453,116      2,936,435
    Costs related to service and repair fees -
     related parties                                  32,536         51,684
    Costs related to management and other fees     8,733,823      6,781,638
    Costs related to management and other fees
     - related medical practices                   3,588,282      2,941,192
  Research and development                         1,242,656      1,440,032
    Selling, general and administrative,
     inclusive of compensatory element of
     stock issuances of $180,418 and $204,486
     for the years ended June 30, 2012 and
     2011, respectively                            8,749,090      8,462,335
  Provision for bad debts                          1,050,442        963,009
                                               -------------  -------------
      Total Costs and Expenses                    32,237,868     29,344,926
                                               -------------  -------------
    Income from Operations                         7,206,551      3,791,469
Other Income and (Expenses):
Interest expense                                    (478,663)      (514,703)
Interest expense - related parties                         -         (3,829)
Investment income                                    243,254        226,610
Interest income - related parties                          -          1,564
Other income (expense) - net                          45,056       (116,617)
                                               -------------  -------------
Income Before Provision For Income Taxes and
 Non Controlling Interests                         7,016,198      3,384,494
Provision for Income Taxes                           141,125         75,475
                                               -------------  -------------
Net Income                                     $   6,875,073  $   3,309,019
                                               -------------  -------------
Net Income - Non Controlling Interests            (1,098,592)      (148,109)
Net Income - Controlling Interests             $   5,776,481  $   3,160,910
                                               -------------  -------------
Net Income Available to Common Stockholders    $   5,392,212  $   2,941,026
                                               =============  =============
Net Income Available to Class A Non-Voting
 Preferred Stockholders                        $     286,406  $     163,886
                                               =============  =============
Net Income Available to Class C Common
 Stockholders                                  $      97,863  $      55,998
                                               =============  =============
Basic Net Income Per Common Share Available to
 Common Stockholders                           $        0.93  $        0.56
                                               =============  =============
Diluted Net Income Per Common Share Available
 to Common Stockholders                        $        0.91  $        0.55
                                               =============  =============
Basic and Diluted Income Per Share - Common C  $        0.26  $        0.15
                                               =============  =============
Weighted Average Basic Shares Outstanding -
 Common Stockholder                                5,778,695      5,264,795
                                               =============  =============
Weighted Average Diluted Shares Outstanding -
 Common Stockholder                                5,906,199      5,392,299
                                               =============  =============
Weighted Average Basic Shares Outstanding -
 Class C Common                                      382,513        382,513
                                               =============  =============
Weighted Average Diluted Shares Outstanding -
 Class C Common                                      382,513        382,513
                                               =============  =============

Contact:
Daniel Culver
Director of Communications
E-mail: Email Contact

Cardium (CXM) Announces the Acquisition of To Go Brands

GreeneStone (GRST) Muskoka Once Again Featured on Intervention Canada

GreeneStone Healthcare Corp. (OTCBB: GRST) (“GreeneStone” or “the Company”) is excited to highlight that the GreeneStone Muskoka addiction treatment clinic was featured on Intervention Canada on the Slice Network on Sunday evening, September 30, 2012 at 8:00 pm ET. Andrew Galloway, GreeneStone’s Vice President – Outpatient & Aftercare is a leading interventionist used on the show and performed the intervention on last night’s episode. GreeneStone Muskoka serves as the facility to which the subject of the intervention, is sent for recovery. The episode aired on Sunday, September 30, 2012 at 9 pm ET and can be viewed on the Slice Canada website when available at:

http://www.slice.ca/Shows/InterventionCanada/EpisodeGuides.aspx?Title_ID=266021

GreeneStone Muskoka was previously featured on the season premiere of the second season of Intervention Canada on August 27, 2012. That episode, as well as a video profile on the GreeneStone Muskoka facility, can be viewed on the Slice Canada website at:

http://www.slice.ca/Slice/Watch/Default.aspx?ID=v&categoryid=2273420202

Intervention Canada is a powerful and gripping television series in which people confront their darkest demons and seek a route to redemption. The series follows the format of the multiple Emmy-nominated ground-breaking U.S. series. It profiles people whose dependencies on drugs and alcohol or other compulsive behavior have brought them to a point of personal crisis that culminates in an intervention with families and professionals offering assistance. In the latest episode featuring GreeneStone Muskoka, titled “Katie,” Andrew Galloway helps 24-year-old Katie and her mother intervene with Katie’s opiate addiction.

“GreeneStone is proud to be associated with Intervention Canada on the Slice Network in an endeavor that brings much needed awareness to the issue of addiction, as well as the cause of mental illness, in general. One in five people will experience a form of mental illness at some point and most will be reluctant to talk to a co-worker, friend or family member about their struggle, let alone seek treatment. GreeneStone is among a growing number of organizations that have joined the cause to de-stigmatize and address the mental illness crisis head on,” commented Shawn Leon, CEO of GreeneStone Healthcare Corp.

For every $5 spent on drug rehabilitation by the Canadian government, $95 is spent on incarceration of drug users (Health Officer’s Council of BC). At the same time, substance abuse costs the Canadian healthcare system an estimated $8 billion annually and the economy an estimated $34 billion (Canadian Centre on Substance Abuse). The majority of the economic cost of substance abuse – an estimated 85% – is due to lost productivity. As such, GreeneStone has focused on Boomers, executives, and professionals as its primary patient stream (with the 18-30 year old segment as the secondary stream).

For more information about GreeneStone Muskoka, visit the official website at www.greenestone.net.

Follow GreeneStone Healthcare Corp. and the company’s activities at the following Facebook sites:

GreeneStone Muskoka: https://www.facebook.com/pages/GreeneStone-Muskoka/510641255628356

GreeneStone Yorkville: https://www.facebook.com/pages/GreeneStone-Yorkville/452197614820117

About GreeneStone Healthcare Corporation

GreeneStone Healthcare Corp. (OTCBB: GRST) is a provider of mental health services, specializing in the areas of addiction treatment, eating disorders, nutrition and weight loss, and executive healthcare. GreeneStone is among the many nascent healthcare companies re-defining the healthcare space for the modern economy, which include Roche Holding Ltd. (OTCQB: RHHBY), Sarepta Therapeutics Inc. (NASDAQ: SRPT), Nektar Therapeutics (NASDAQ: NKTR), Celldex Therapeutics, Inc. (NASDAQ: CLDX), Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN), Zogenix, Inc. (NASDAQ: ZGNX). The company operates medical and healthcare clinics in Ontario, Canada, serving a North American and international clientele. GreeneStone’s clinics meet several ends: (1) GreeneStone adds overflow capacity to an increasingly stretched public healthcare system in Canada, (2) GreeneStone mental health clinics provide private alternatives to publicly available but highly underserviced healthcare subsectors, and (3) GreeneStone meets newly developing healthcare needs undisturbed by the public/private market, such as eating disorders. The company is headquartered in Toronto, Canada.

Notice Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). To the extent that any statements made in this press release contain information that is not historical, these statements are essentially forward-looking. Forward-looking statements can be identified by the use of words such as “expect,” “plan,” “will,” “may,” “anticipate,” “believe,” “should,” “intend,” “estimate,” and variations of such words. Forward-looking statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, those risks and uncertainties contained in this press release and those identified in the periodic reports that the company files with the Securities and Exchange Commission (the “SEC”) pursuant to the Exchange Act.

Investor information and email sign-up:

http://www.greenestoneinvestor.com